长病程1型糖尿病患者的白细胞端粒长度、DNA氧化与下肢截肢风险
在GENEDIAB 1型糖尿病队列478例高血管风险患者中,基线LTL缩短与基线下肢截肢史及10年随访新发下肢截肢风险独立相关;血浆8-OHdG升高也与新发下肢截肢相关,但部分依赖混杂变量。
要点
- 基线有下肢截肢史与较短LTL相关(T3 vs T1 OR 0.41),与8-OHdG无关。
- 10年随访新发下肢截肢34例(12.3%),较短LTL与新发风险相关(T3 vs T1 HR 0.29)。
- 血浆8-OHdG升高与新发下肢截肢相关(T3 vs T1 HR 3.11),但部分依赖混杂变量。
核心结论
- 首次报告1型糖尿病中LTL缩短与下肢截肢超额风险独立相关;高血浆8-OHdG也与新发下肢截肢相关,但部分依赖混杂变量。
研究设计与样本
- GENEDIAB 1型糖尿病队列研究,基线检测LTL(定量PCR)和血浆8-OHdG(免疫分析法),共478例参与者(男性56%,平均±SD年龄45±12岁,糖尿病病程29±10年)。
主要发现
- 基线84例有下肢截肢史,与较短LTL相关(T2 vs T1 OR 0.62 [95%CI 0.32-1.22],T3 vs T1 OR 0.41 [0.20-0.84]),与血浆8-OHdG无关(T2 vs T1 OR 1.16 [0.56-2.39],T3 vs T1 OR 1.24 [0.61-2.55])。
- 10年随访期间34例(12.3%)新发下肢截肢;新发者LTL较短(T2 vs T1 HR 0.25 [95%CI 0.08-0.67],T3 vs T1 HR 0.29 [0.10-0.77])。
- 新发者血浆8-OHdG较高(T2 vs T1 HR 2.20 [95%CI 0.76-7.35],T3 vs T1 HR 3.11 [1.07-10.32])。
- 两种生物标志物对下肢截肢的关联未观察到显著交互作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Telomere shortening and DNA oxidation are associated with premature vascular aging, which may be involved in lower-extremity amputation (LEA). We sought to investigate whether leukocyte telomere length (LTL) and plasma 8-hydroxy-2'-deoxyguanosine (8-OHdG), a biomarker of DNA oxidation, were associated with LEA in subjects with type 1 diabetes at high vascular risk. RESEARCH DESIGN AND METHODS: LTL (quantitative PCR) and plasma 8-OHdG concentrations (immunoassay method) were assessed at baseline in the GENEDIAB (Génétique de la Néphropathie Diabétique) type 1 diabetes cohort. Logistic and Cox proportional hazards regression models were fitted to estimate odds ratio (OR) (at baseline) and hazard ratio (HR) (during follow-up), with related 95% CI, by increasing biomarker tertiles (T1, T2, T3). RESULTS: Among 478 participants (56% male, mean ± SD age 45 ± 12 years and diabetes duration 29 ± 10 years), 84 patients had LEA at baseline. Baseline history of LEA was associated with shorter LTL (OR for T2 vs. T1 0.62 [95% CI 0.32-1.22] and for T3 vs. T1 0.41 [0.20-0.84]) but not with plasma 8-OHdG (1.16 [0.56-2.39] and 1.24 [0.61-2.55], respectively). New cases of LEA occurred in 34 (12.3%) participants during the 10-year follow-up. LTL were shorter (HR T2 vs. T1 0.25 [95% CI 0.08-0.67] and T3 vs. T1 0.29 [0.10-0.77]) and plasma 8-OHdG higher (2.20 [0.76-7.35] and 3.11 [1.07-10.32]) in participants who developed LEA during follow-up compared with others. No significant interaction was observed between biomarkers on their association with LEA. CONCLUSIONS: We report the first independent association between LTL shortening and excess risk of LEA in type 1 diabetes. High plasma 8-OHdG was also associated with incident LEA but partly dependent on cofounding variables.
引用
- Sanchez M, Hoang S, Kannengiesser C, et al. Leukocyte Telomere Length, DNA Oxidation, and Risk of Lower-Extremity Amputation in Patients With Long-standing Type 1 Diabetes. Diabetes Care. 2020. PMID: 31988064. doi:10.2337/dc19-0973
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。